Century Therapeutics, Inc. (IPSC) Institutional Ownership

Ownership Summary

According to SEC filings for the period ending December 2025, Century Therapeutics, Inc. (NASDAQ:IPSC) is held by 6 institutional firms.

• These investors collectively held 4.3% of the company's total shares outstanding in December 2025, down from 24.5% in September 2025.
• In percentage terms, this reflects as a holdings change of 6.42% quarter on quarter, and a decrease of 91.67% year over year.
• A review of institutional activity for Century Therapeutics shows 1 of 6 filers increasing their positions, while 0 reduced their stake, and 5 remained unchanged.
• The aggregate institutional position in Century Therapeutics now stands at 3.55Mn shares as of December 2025, after investors increased their holdings (up by 214.16K shares quarter on quarter which is down 32.84Mn shares year over year).
• With 2.10Mn shares, VANGUARD GROUP INC commands the largest institutional position in Century Therapeutics as of December 31, 2025, equating to 2.54% of the company.
• Among the most significant buyers of Century Therapeutics during December 2025 were UBS Group AG (214.16K).
• The top 6 institutional holders of Century Therapeutics for the quarter ending December 2025 included VANGUARD GROUP INC (2.10Mn), Syncona Portfolio Ltd (1.21Mn), UBS Group AG (214.50K), Quadrant Private Wealth Management, LLC (15.29K), SBI Securities Co., Ltd. (1.53K), NISA INVESTMENT ADVISORS, LLC (883).